Verona Pharma News

Verona Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 10 08:59 ET

Verona Pharma | 8-K: Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 9 07:27 ET

Verona Pharma | 8-K: Current report

May 9 07:22 ET

Verona Pharma | 8-K: Current report

Apr 30 16:17 ET

Verona Pharma | DEF 14A: Definitive information statements

Mar 20 08:52 ET

Verona Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 8 16:23 ET

Verona Pharma | 8-K: Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Feb 29 06:13 ET

Verona Pharma | 8-K: Current report

Feb 2 06:10 ET

Verona Pharma | 8-K: Current report

Jan 2 00:00 ET

Verona Pharma | 8-K: Current report

Dec 18, 2023 16:15 ET

Verona Pharma | 8-K: Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 2, 2023 06:24 ET

Verona Pharma | 8-K: Current report

Sep 11, 2023 06:02 ET

Verona Pharma | 8-K: Current report

Sep 1, 2023 16:05 ET

Verona Pharma | 8-K: Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 3, 2023 06:11 ET

Verona Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 9, 2023 16:08 ET

Verona Pharma | 8-K: Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 9, 2023 06:13 ET

Verona Pharma | 8-K: Current report

May 1, 2023 17:21 ET

Verona Pharma | DEF 14A: Definitive proxy statements

Mar 21, 2023 08:00 ET

Verona Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 7, 2023 17:25 ET

Verona Pharma | 8-K: Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Mar 7, 2023 06:06 ET